Volume | 35,421 |
|
|||||
News | (1) | ||||||
Day High | 7.03 | Low High |
|||||
Day Low | 6.46 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
AirSculpt Technologies Inc | AIRS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
6.68 | 6.46 | 7.03 | 6.56 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
649 | 35,421 | $ 6.79 | $ 240,437 | - | 2.69 - 9.935 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:27:39 | 5 | $ 6.845 | USD |
AirSculpt Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
389.54M | 56.78M | - | 168.79M | -14.68M | -0.26 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
AirSculpt Technologies News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIRS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.75 | 7.03 | 6.03 | 6.53 | 84,374 | 0.11 | 1.63% |
1 Month | 7.76 | 8.1732 | 6.03 | 7.04 | 67,805 | -0.90 | -11.6% |
3 Months | 7.75 | 9.935 | 6.03 | 8.12 | 83,335 | -0.89 | -11.48% |
6 Months | 4.85 | 9.935 | 4.43 | 7.16 | 139,970 | 2.01 | 41.44% |
1 Year | 6.55 | 9.935 | 2.69 | 5.53 | 226,494 | 0.31 | 4.73% |
3 Years | 12.84 | 18.48 | 2.69 | 8.25 | 216,263 | -5.98 | -46.57% |
5 Years | 12.84 | 18.48 | 2.69 | 8.25 | 216,263 | -5.98 | -46.57% |
AirSculpt Technologies Description
AirSculpt Technologies Inc is a provider of body contouring procedures delivering a premium consumer experience. It provides a custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. Its mission is to generate the best results for patients. |